A total of 112 subjects enrolled in the EMPATIa study, 105 were eligible, 19 of whom were Coutinho stage 1 polyneuropathy ATTRv patients and 86 AC of a pathogenic mutation in the TTR gene (Supplementary Fig. S1). This evidence concerns the gene TTR and polyneuropathy.